发明名称 Desulphatohirudin for treating prevascularised metastasised tumors
摘要 Disclosed is the use of a formulation comprising an effective amount of desulphatohirudin or a functional desulphatohirudin variant in the manufacture of a medicament formulated for treating prevascularised metastasised tumour to effect regression of the tumour.
申请公布号 NZ551146(A) 申请公布日期 2009.04.30
申请号 NZ20050551146 申请日期 2005.04.05
申请人 CANYON PHARMACEUTICALS, INC 发明人 YU, CHENG-DER TONY
分类号 A61K38/54;A61K38/58;(IPC1-7):A01N37/18;A61K38/00;A61P35/00 主分类号 A61K38/54
代理机构 代理人
主权项
地址